NEW YORK, April 22, 2022 /PRNewswire/ — Overview of spasticity treatment market facts-
-
Total Pages: 120
-
Companies: 10+ – Including Allergan Plc, Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Covis Pharma BV, Dr. Reddys Laboratories Ltd., Endo International Plc, F. Hoffmann La Roche Ltd., Hikma Pharmaceuticals Plc, Ipsen Pharma, Jazz Pharmaceuticals Plc, Mayne Pharma Group Ltd., Merz Pharma GmbH and Co. KGaA, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd., US WorldMeds, Cadila Healthcare Ltd., Medtronic Plc and JPN Pharma Pvt . ltd. among others.
-
Cover: Main Drivers, Trends and Challenges; Product information and news; Value chain analysis; Parent market analysis; Landscape of vendors; COVID Impact and Recovery Analysis
-
segments: Type (drug therapy and physiotherapy)
-
Geographies: North America, Europe, Asiaand Rest of the World (ROW)
Learn more about market dynamics. Download our sample report
the spasticity treatment market the size should increase by $1.11 billion from 2021 to 2026, at an accelerated pace CAGR of 4.17% according to Technavio’s latest market report. 41% of market growth will come from North America during the forecast period. The United States is the key market for the spasticity treatment market in North America. Market growth in this region will be slower than market growth in Asia. Increase in high risk factors for spasticity in the region will facilitate spasticity treatment market growth in North America over the forecast period.
Download sample: for more information on key countries in North America
Overview of Suppliers-
the The spasticity treatment market is fragmented, and vendors are deploying growth strategies such as focusing on delivering products through multiple distribution channels to compete in the market.
Find additional highlights on vendors and their product offerings. Download sample report
Latest drivers and trends driving the market-
Find additional insights on various other market drivers and trends – Download sample report.
Did not find what you were looking for ? Customize report-
Don’t miss the opportunity to talk to our analyst and learn more about this market report. Our analysts can also help you customize this report to suit your needs. Our analysts and industry experts will work directly with you to understand your needs and provide you with personalized data in a short period of time.
For customization – Talk to our analyst now!
Related Reports
-
the hepatitis B therapeutics market The market share is expected to increase by USD 471.49 million from 2021 to 2026, and the market growth momentum will accelerate at a CAGR of 3.29%. Download a free sample now!
-
the smart pill drug delivery market The market share is expected to increase by USD 4.69 billion from 2021 to 2026, and the market growth momentum will accelerate at a CAGR of 18.66%. Download a free sample now!
|
Spasticity Treatment Market Scope |
|
|
Report cover |
Details |
|
Page number |
120 |
|
base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum and CAGR |
Accelerate at a CAGR of 4.17% |
|
Market Growth 2022-2026 |
$1.11 billion |
|
Market structure |
Fragmented |
|
Annual growth (%) |
3.65 |
|
Successful market contribution |
North America at 41% |
|
Competitive landscape |
Leading companies, competitive strategies, scope of consumer engagement |
|
Profiled companies |
Allergan Plc, Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Covis Pharma BV, Dr. Reddys Laboratories Ltd., Endo International Plc, F. Hoffmann La Roche Ltd., Hikma Pharmaceuticals Plc, Ipsen Pharma, Jazz Pharmaceuticals Plc, Mayne Pharma Group Ltd., Merz Pharma GmbH and Co. KGaA, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd., US WorldMeds, Cadila Healthcare Ltd., Medtronic Plc and JPN Pharma Pvt. ltd. |
|
Market dynamics |
Parent Market Analysis, Market Growth Drivers and Barriers, Fast and Slow Growing Segment Analysis, COVID 19 Impact and Future Consumer Dynamics, Market Condition Analysis for the Forecast Period. |
|
Personalization area |
If our report does not include the data you are looking for, you can contact our analysts and customize the segments. |
Contents:
1. Summary
2 Market landscape
3 Market sizing
4 Five forces analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic landscape
8 drivers, challenges and trends
9 Supplier Landscape
10 Vendor Analysis
11 Appendix
About Us
Technavio is a global leader in technology research and consulting. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s reporting library consists of over 17,000 reports and counts, spanning 800 technologies, spanning 50 countries. Their customer base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market intelligence to identify opportunities in existing markets and potentials and assess their competitive positions in changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
E-mail: media@technavio.com
Website: www.technavio.com/
Show original content to download multimedia:https://www.prnewswire.com/news-releases/spasticity-treatment-market—41-of-growth-to-originate-from-north-america-evolving-opportunities-with-allergan-plc–alembic -pharmaceuticals-ltd–technavio-301530301.html
SOURCETechnavio
